1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Bruker Corporation

Bruker Corporation

BRKRP
Bruker CorporationUS flagNASDAQ
461.01
USD
+15.76
- -
9.52BMarket Cap
Bruker Corporation
BRKRP
(NASDAQ)

Recent

price

461.01

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
1,305
1,652
1,791
1,839
1,809
1,624
1,611
1,766
1,896
2,073
1,988
2,418
2,531
2,964
3,366
3,436
3,458
Sales/Revenue/Turnover
12.38
9.95
10.19
9.28
7.46
9.86
12.88
13.53
14.63
14.73
13.45
17.64
18.27
16.5
11.26
6.87
6.06
Operating Margin (%)
36
53
59
61
60
53
54
64
65
76
80
89
89
115
184
220
228
Depreciation Expense
95
92
78
80
57
102
154
79
180
197
158
277
297
427
113
-9
-12
Net Income, GAAP
35.51
35.4
43.46
34.35
41.16
18.05
13.01
59.4
26.03
29.39
28.52
28.71
28.12
21.63
44.18
133.18
122.87
Effective Tax Rate (%)
7.31
5.59
4.33
4.35
3.13
6.26
9.53
4.45
9.48
9.51
7.94
11.46
11.72
14.41
3.36
-0.25
-0.34
Profit Margin (%)
220
438
628
783
784
677
751
834
705
1,151
1,133
1,533
1,199
962
772
933
748
Working Capital
87
219
336
354
354
265
392
416
323
860
889
1,264
1,235
1,235
2,181
1,991
1,663
LT Debt
527
625
710
850
772
733
693
734
928
938
974
1,085
1,132
1,413
1,815
2,510
2,503
Total Equity
14.23
11.28
9.85
9.56
6.6
11.88
16.72
8.4
16.32
13.43
9.83
13.32
13.12
14.08
5.93
-1.77
-1.18
Return on Invested Capital (%)
18.61
13.58
10.54
9.58
6.23
10.63
14.05
6.22
13.2
11.33
7.27
10.5
9.75
12.61
3.3
-0.63
-0.63
Return on Capital (%)
31.47
23.25
16.08
14.28
9.01
14.34
18.66
8.59
17.55
16.57
11.76
18.06
16.53
20.09
4.78
-0.94
-1.52
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
24
52
8
LT Borrowings
1,984
1,852
1,663
LT Finance Leases
- -
139
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
152
152
152
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
2,351
2,212
2,104
Cash, Cash Equivalents & STI
293
299
133
Accounts Receivable, Net
551
545
543
Inventories
1,197
1,095
1,122
Total Current Liabilities
1,268
1,279
1,355
Payables & Accruals
184
441
269
ST Debt
24
52
8
Deferred Revenue
455
441
480

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
13.91%
21.45%
38.29%
Free Cash Flow
-2.97%
-21.82%
-89.78%
Net Income, GAAP
6.63%
-10.89%
-107.6%
Sales/Revenue/Turnover
8.05%
11.82%
2.08%
Total Cash Common Dividend
- -
-2.84%
-37.09%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
722
801
864
980
3,366
2025
801
797
860
977
3,436
2026
823
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Spineway S.A. (ALSPW.PA)
STERIS plc (STE)
IVIM Technology (460470.KQ)
Ypsomed Holding AG (YPHDF)
VolitionRX Ltd (VNRX)
C-Rad AB (publ) (CRAD-B.ST)
Business
Bruker Corporation develops, manufactures, and distributes advanced scientific instrumentation and analytical and diagnostic tools, enabling clients to investigate biological and material structures at the microscopic, molecular, and cellular levels. The company functions through several key operational segments. Its Bruker BioSpin Group delivers life science instruments utilizing magnetic resonance technologies, including NMR and EPR spectrometers, along with advanced imaging systems like MRI, PET, SPECT, CT, Optical, and MPI modalities. The Bruker CALID Group concentrates on life science mass spectrometry and ion mobility spectrometry solutions, providing analytical and process analysis instruments. This segment also encompasses infrared and Raman molecular spectroscopy technologies and detection systems for chemical, biological, radiological, nuclear, and explosive substances. The Bruker Scientific Instruments (BSI) Nano Segment offers sophisticated X-ray instruments, atomic force microscopy, advanced fluorescence optical microscopy systems, analytical tools for electron microscopes, and X-ray metrology. It further provides defect-detection equipment for semiconductor process control, portable X-ray fluorescence spectrometry, spark optical emission spectroscopy platforms, and ChipCytometry products and services for spatial proteomics, multi-omics, and spatial genomics research. The Bruker Energy & Supercon Technologies (BEST) segment is engaged in superconducting and non-superconducting materials and devices, supporting applications in renewable energy, energy infrastructure, healthcare, and large-scale scientific research. Bruker's portfolio recently expanded through strategic acquisitions in spatial biology, molecular diagnostics, and lab automation platforms. Founded in 1960 by Günther Laukien and Emil Bruker in Karlsruhe, Germany, the company maintains its global headquarters in Billerica, Massachusetts.

Company News

APIChatGPT

  • seekingalpha.com

    Bruker Corporation (BRKR) Q1 2026 Earnings Call Transcript